Engineering HBV-specific T cells for the treatment of HBV-related HCC and HBV infection: Past, Present, and Future. Editorial on “Genetically-modified, redirected T cells target hepatitis B surface antigen-positive hepatocytes and hepatocellular carcinoma lesions in a clinical setting”

Affiliations

Antonio Bertoletti: Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore
Anthony T Tan: Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore

Abstract

No abstracts available.

ISSN: 2287-2728 (Print); 2287-285X (Online)
Publisher: Korean Association for the Study of the Liver
Country of publisher: Korea, Republic of
LCC subjects: Medicine: Internal medicine: Specialties of internal medicine: Diseases of the digestive system. Gastroenterology
Website: http://www.e-cmh.org